Mycophenolate mofetil decreases rejection in simultaneous pancreas- kidney transplantation when combined with tacrolimus or cyclosporine

Transplantation

Volumn 64, Issue 12, 1997, Pages 1695-1700

  Stegall, Mark D ^a   Simon, Marta ^a   Wachs, Michael E ^a   Chan, Lawrence ^a   Nolan, Charles ^a   Kam, Igal ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN A; HEMOGLOBIN A1C; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; CHOLECYSTOKININ BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT REJECTION; HEALTH CARE COST; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MALE; METABOLIC REGULATION; MIGRAINE; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION;

ADULT; AGED; COSTS AND COST ANALYSIS; CREATINE; CYCLOSPORINE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MUROMONAB-CD3; MYCOPHENOLIC ACID; PANCREAS TRANSPLANTATION; PROSPECTIVE STUDIES; TACROLIMUS; TIME FACTORS;

EID: 0031450006     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712270-00011     Document Type: Conference Paper

References (17)

1. Sutherland DER, Gruessner A. Pancreas transplantation in the United States as reported to the United Network for Organ Sharing (UNOS) and analyzed by the International Pancreas Transplant Registry. In: Terasaki PI, Cecka JM, eds. Clinical Transplants 1996. Los Angeles: UCLA Tissue Typing Laboratory, 1997.
2. Stratta RF, Tailor RJ, Gill IS. Pancreas transplantation: a managed cure approach to diabetes. Curr Prob Gen Surg 1996; 33: 713.
3. Sollinger HW, Ploeg RJ, Eckhoff DE, et al. Two hundred consecutive simultaneous pancreas-kidney transplants with bladder drainage. Surgery 1993; 114: 736.
4. Stratta RJ, Sollinger HW, Perlman SB, et al. Early diagnosis and treatment of pancreas allograft rejection. Transplant Int 1988; 1: 6.
5. Gaber AO, Shokouh-Amiri MH, Hathaway DK, et al. Results of pancreas transplantation with portal and enteric drainage. Ann Surg 1994; 221: 613.
6. Gruessner RWG, Burke GW, Stratta R, et al. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Transplantation 1996; 61: 261.
7. El-Ghoroury M, Hariharan S, Peddi VR, et al. Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients. Transplant Proc 1997; 29: 649.
8. Rayhill SC, Odorico JS, Kirk A, et al. Mycophenolate mofetil in simultaneous pancreas-kidney transplantation. Abstract presented at the 16th International Congress of the Transplantation Society, 1996.
9. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil (MMF). Lancet 195; 345: 1321.
10. Sollinger HW for the U.S. Renal Transplant Mycophenolate Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225.
11. Tricontinental Mycophenolate Mofetil Renal Transplant Study Group. A blinded, randomized clinical trial of mycophenolate for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 61: 1029.
12. Halloran P, Hathew T, Tomlanovich S, et al. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. Transplantation 1997; 63: 39.
13. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS for the FK506 Kidney Transplant Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997; 63: 977.
14. Stratta RJ for the FK/MMF Multi-Center Study Group. Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: a multi-center report. Transplant Proc 1997; 29: 654.
15. Manez R, Jain A, Marino IR, Thomson AW. Comparative evaluation of tacrolimus (FK506) and cyclosporine A as immunosuppressive agents. Transplant Rev 1995; 9: 63.
16. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423.
17. The US Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 31: 1110.